Egbert Scholtens
- Pharmacology top 1%
- Berberine and alkaloids research 4
- Biochemistry top 2%
-
- Cardiac electrophysiology and arrhythmias 10
- Renin-Angiotensin System Studies 6
- Heart Failure Treatment and Management 4
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 7
-
- Nitric Oxide and Endothelin Effects 6
-
- Ion channel regulation and function 5
- Receptor Mechanisms and Signaling 4
- Co-authors
- Gerard J. MulderWiek H. van GilstKlaas R. KrijgsheldHenk KosterH. WesselingK. Sandy PangGrietus MulderP. A. de Graeff
- Journals
- Biochemical Pharmacology (8 papers)Journal of Cardiovascular Pharmacology (5 papers)Cardiovascular Research (4 papers)
- Partner nations
- NetherlandsGermanyCanada
In The Last Decade
Egbert Scholtens
45 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 102
- Pharmacology 287
- Biochemistry 186
- Cardiology and Cardiovascular Medicine 344
- Oncology 244
- Endocrinology, Diabetes and Metabolism 131
Countries citing papers authored by Egbert Scholtens
This map shows the geographic impact of Egbert Scholtens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Egbert Scholtens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Egbert Scholtens more than expected).
Fields of papers citing papers by Egbert Scholtens
This network shows the impact of papers produced by Egbert Scholtens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Egbert Scholtens. The network helps show where Egbert Scholtens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Egbert Scholtens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 13 | |
| 2 | 2003 | 50 | |
| 3 | 2000 | 8 | |
| 4 | 1997 | 43 | |
| 5 | 1997 | 4 | |
| 6 | 1994 | 15 | |
| 7 | 1994 | 8 | |
| 8 | 1993 | 22 | |
| 9 | 1993 | 53 | |
| 10 | 1991 | 40 | |
| 11 | 1990 | 2 | |
| 12 | 1988 | 33 | |
| 13 | 1983 | 9 | |
| 14 | 1983 | 58 | |
| 15 | 1982 | 13 | |
| 16 | 1981 | 41 | |
| 17 | 1981 | 48 | |
| 18 | 1980 | 55 | |
| 19 | 1979 | 54 | |
| 20 | 1977 | 109 |
About Egbert Scholtens
Egbert Scholtens is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Pharmacology, Clinical Biochemistry and Physiology, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (10 papers), Drug Transport and Resistance Mechanisms (7 papers), Nitric Oxide and Endothelin Effects (6 papers), Renin-Angiotensin System Studies (6 papers), Ion channel regulation and function (5 papers), Heart Failure Treatment and Management (4 papers), Berberine and alkaloids research (4 papers) and Receptor Mechanisms and Signaling (4 papers). The work is most often cited by research in Pharmacology (287 citations), Biochemistry (186 citations), Cardiology and Cardiovascular Medicine (344 citations), Oncology (244 citations) and Endocrinology, Diabetes and Metabolism (131 citations). Egbert Scholtens has collaborated with scholars based in Netherlands, Germany and Canada. Frequent co-authors include Gerard J. Mulder, Wiek H. van Gilst, Klaas R. Krijgsheld, Henk Koster, H. Wesseling, K. Sandy Pang, Grietus Mulder, P. A. de Graeff, Dirk K. F. Meijer and G J Mulder. Their work appears in journals such as Biochemical Pharmacology, Journal of Cardiovascular Pharmacology, Cardiovascular Research, Journal of Pharmacology and Experimental Therapeutics and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.